Evidence map›Paper›PMID 27553035›Full record

ArticleNeural development2016

Lmx1b is required for the glutamatergic fates of a subset of spinal cord neurons.

William C Hilinski, Jonathan R Bostrom, Samantha J England, José L Juárez-Morales, Sarah de Jager, Olivier Armant, Jessica Legradi, Uwe Strähle, Brian A Link, Katharine E Lewis

Open access · goldAbstract read
In one paragraph

Article in Neural development, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.6field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Lessons learned from a muscle study in nail-patella syndrome.Orphanet journal of rare diseases · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Excitatory Spinal Lhx9-Derived Interneurons Modulate Locomotor Frequency in Mice.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  8. Article
  9. iScience · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

William C HilinskiDepartment of Biology, Syracuse University, 107 College Place, Syracuse, NY, 13244, USA.
Jonathan R BostromDepartment of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, 8701 Watertown Plank Rd., Milwaukee, WI, 53226, USA.
Samantha J EnglandDepartment of Biology, Syracuse University, 107 College Place, Syracuse, NY, 13244, USA.
José L Juárez-MoralesDepartment of Biology, Syracuse University, 107 College Place, Syracuse, NY, 13244, USA.
Sarah de JagerDepartment of Physiology, Development and Neuroscience, University of Cambridge, Downing Street, Cambridge, CB2 3DY, UK.
Olivier ArmantInstitute of Toxicology and Genetics, Karlsruhe Institute of Technology (KIT), Postfach 3640, 76021, Karlsruhe, Germany.
Jessica LegradiInstitute of Toxicology and Genetics, Karlsruhe Institute of Technology (KIT), Postfach 3640, 76021, Karlsruhe, Germany.
Uwe SträhleInstitute of Toxicology and Genetics, Karlsruhe Institute of Technology (KIT), Postfach 3640, 76021, Karlsruhe, Germany.
Brian A LinkDepartment of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, 8701 Watertown Plank Rd., Milwaukee, WI, 53226, USA.
Katharine E LewisDepartment of Biology, Syracuse University, 107 College Place, Syracuse, NY, 13244, USA. kelewi02@syr.edu.
Syracuse University · USKarlsruhe Institute of Technology · DEMedical College of Wisconsin · USUniversity of Cambridge · GB

Funding

Signaling and Gene Interactions Underlying Glaucoma Risk PhenotypesR01EY016060 · NEI · MEDICAL COLLEGE OF WISCONSIN · PI LINK, BRIAN A · 2005 to 2015
$3.9M
Specification of Functional Characteristics of Spinal Cord InterneuronsR01NS077947 · NINDS · SYRACUSE UNIVERSITY · PI LEWIS, KATHARINE EMMA · 2014 to 2019
$1.6M
Identifying transcription factors expressed by ventral spinal cord interneuronsR21NS073979 · NINDS · SYRACUSE UNIVERSITY · PI LEWIS, KATHARINE EMMA · 2011 to 2013
$454k
NEI NIH HHS R01 EY016060NINDS NIH HHS R01 NS077947NINDS NIH HHS R21 NS073979
6 · The paper itself

Abstract

backgroundAlterations in neurotransmitter phenotypes of specific neurons can cause imbalances in excitation and inhibition in the central nervous system (CNS), leading to diseases. Therefore, the correct specification and maintenance of neurotransmitter phenotypes is vital. As with other neuronal properties, neurotransmitter phenotypes are often specified and maintained by particular transcription factors. However, the specific molecular mechanisms and transcription factors that regulate neurotransmitter phenotypes remain largely unknown.

methodsIn this paper we use single mutant, double mutant and transgenic zebrafish embryos to elucidate the functions of Lmx1ba and Lmx1bb in the regulation of spinal cord interneuron neurotransmitter phenotypes.

resultsWe demonstrate that lmx1ba and lmx1bb are both expressed in zebrafish spinal cord and that lmx1bb is expressed by both V0v cells and dI5 cells. Our functional analyses demonstrate that these transcription factors are not required for neurotransmitter fate specification at early stages of development, but that in embryos with at least two lmx1ba and/or lmx1bb mutant alleles there is a reduced number of excitatory (glutamatergic) spinal interneurons at later stages of development. In contrast, there is no change in the numbers of V0v or dI5 cells. These data suggest that lmx1b-expressing spinal neurons still form normally, but at least a subset of them lose, or do not form, their normal excitatory fates. As the reduction in glutamatergic cells is only seen at later stages of development, Lmx1b is probably required either for the maintenance of glutamatergic fates or to specify glutamatergic phenotypes of a subset of later forming neurons. Using double labeling experiments, we also show that at least some of the cells that lose their normal glutamatergic phenotype are V0v cells. Finally, we also establish that Evx1 and Evx2, two transcription factors that are required for V0v cells to acquire their excitatory neurotransmitter phenotype, are also required for lmx1ba and lmx1bb expression in these cells, suggesting that Lmx1ba and Lmx1bb act downstream of Evx1 and Evx2 in V0v cells.

conclusionsLmx1ba and Lmx1bb function at least partially redundantly in the spinal cord and three functional lmx1b alleles are required in zebrafish for correct numbers of excitatory spinal interneurons at later developmental stages. Taken together, our data significantly enhance our understanding of how spinal cord neurotransmitter fates are regulated.

Indexed as

AnimalsCell DeathGlutamic AcidHomeodomain ProteinsInterneuronsPhenotypeSpinal CordTranscription FactorsVesicular Glutamate Transport Protein 2ZebrafishZebrafish Proteinsevx1 protein, zebrafishEvx2 protein, zebrafishGlutamic AcidHomeodomain Proteinslmx1bb protein, zebrafishTranscription FactorsVesicular Glutamate Transport Protein 2Zebrafish ProteinsCNSdI5ExcitatoryInterneuronLmx1bNeurotransmitterSpinal cordTranscription factorV0vZebrafish

Identifiers

PMID27553035
PMCPMC4995821
OpenAlexW2507504041

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.